Elpidera's Corporate Minority Round

Elpidera raised a round of funding on May 12, 2015. Investors include Moderna Therapeutics.

Elpidera, the third venture company formed by Moderna, is focused exclusively on the advancement of messenger RNA (mRNA) Therapeutics for the treatment of rare diseases. Elpidera, which is derived fro…

Articles about Elpidera's Corporate Minority Round: